Litcius/Paper detail

Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG and Gemcitabine for Non-Muscle Invasive Bladder Cancer

Joshua M. Kuperus, Ross D. Busman, Susan K. Kuipers, Helen T. Broekhuizen, Sabrina L. Noyes, Christopher M. Brede, Conrad M. Tobert, Brian R. Lane

2021Urology18 citationsDOI

Topics & Concepts

MedicineTolerabilityGemcitabineBladder cancerInternal medicineUrologyCancerAdverse effectBladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsUrinary and Genital Oncology Studies
Comparison of Side Effects and Tolerability Between Intravesical Bacillus Calmette-Guerin, Reduced-Dose BCG and Gemcitabine for Non-Muscle Invasive Bladder Cancer | Litcius